Dosing Bupropion and Methylphenidate in Adult Patients
For methylphenidate in adults, start with 5 mg twice daily (before breakfast and lunch) and titrate by 5-10 mg weekly up to a maximum of 60 mg/day, with an average effective dose of 20-30 mg/day. 1 For bupropion, start with 150 mg once daily in the morning for 3 days, then increase to 150 mg twice daily, with a maximum dose of 300 mg/day (450 mg/day for some indications). 2, 3
Methylphenidate Dosing Algorithm
Starting Dose
- Initial: 5 mg twice daily (preferably 30-45 minutes before breakfast and lunch) 1
- Alternative: Can divide into 2-3 times daily dosing 1
Titration Schedule
- Increase by 5-10 mg weekly based on response and tolerability 1
- Monitor closely during the first few days for agitation and insomnia 4
Target and Maximum Doses
- Average effective dose: 20-30 mg/day 1
- Maximum: 60 mg/day 1
- For patients with sleep disturbances, administer last dose before 6 PM 1
Formulation Considerations
- Immediate-release: Peak plasma concentration in 1-3 hours, half-life ~2 hours 4
- Sustained-release: 4-6 hours of clinical action 4
- Newer extended-release: Early peak followed by 8 hours of action 4
- For cancer-related fatigue: 2.5-5 mg daily or twice daily, range 5-30 mg/day divided twice daily 4
Bupropion Dosing Algorithm
Starting Dose (Depression/ADHD)
Titration Schedule
- Day 4 onwards: 150 mg twice daily if tolerated 2, 5
- Maximum: 300 mg/day (some sources allow up to 450 mg/day for specific indications) 6, 3
- Second dose should not be taken late in day to minimize insomnia 2
Special Dosing for Naltrexone-Bupropion ER (Obesity)
If using the combination product:
- Week 1: 1 tablet (8 mg naltrexone/90 mg bupropion) daily in morning 7
- Week 2: 1 tablet twice daily 7
- Week 3: 2 tablets morning, 1 tablet afternoon 7
- Week 4+: Maintenance dose of 2 tablets twice daily 7
Dose Adjustments for Renal/Hepatic Impairment
- Moderate-severe renal impairment: Reduce total daily dose by 50% (1 tablet twice daily for combination product) 7
- End-stage renal disease: Avoid 7
- Moderate-severe hepatic impairment: Maximum 1 tablet daily (for combination product) 7
Critical Safety Considerations
Methylphenidate Contraindications
- Absolute contraindications: Uncontrolled hypertension, underlying coronary artery disease, tachyarrhythmias 4
- Avoid with MAOIs or within 14 days of discontinuation 1
- Monitor blood pressure and heart rate (mean increases: 2-4 mmHg systolic, 3-6 bpm) 1
Bupropion Contraindications
- Seizure disorders or conditions increasing seizure risk (stroke, brain metastases) 2, 7
- Concurrent MAOIs or within 14 days 7
- Closed-angle glaucoma 2
- Patients requiring opioid therapy (for naltrexone-bupropion combination) 7
Common Side Effects
Methylphenidate: Agitation, insomnia (most common), appetite loss, anxiety 4
- Schedule doses early in day to minimize insomnia 4
Bupropion: Dry mouth (most common), nausea, insomnia, headache 2, 5, 8
- Take with food to reduce nausea 5
Efficacy Comparison
While both medications are effective, the evidence shows:
- Methylphenidate response rate: 41-78% in various studies 4
- Bupropion response rate: 53-64% in ADHD studies 9, 10, 11
- Head-to-head trials show comparable efficacy (no significant difference, p > 0.05) 9, 12
- Effect size for bupropion XL in ADHD: 0.6 10
Discontinuation Guidelines
When to Discontinue
- Bupropion (obesity): If <5% weight loss after 12 weeks on maintenance dose 7
- Either medication: If no improvement after 1 month of appropriate dosage adjustment 1
- If paradoxical aggravation of symptoms occurs 1